Briviact

Briviact (brivaracetam) is an antiepileptic drug (AED) indicated for the treatment of partial-onset seizures in patients 1 month of age and older. It works by binding with high affinity to synaptic vesicle protein 2A (SV2A) in the brain, helping to stabilize electrical activity and prevent seizures.

Dosage by Body Weight

For adults and pediatric patients weighing 50 kg or more, the recommended starting dose is 50 mg twice daily. The dose may be adjusted down to 25 mg twice daily or up to 100 mg twice daily based on clinical response and tolerability. For pediatric patients weighing less than 50 kg, the dosage is weight-based, typically administered twice daily as an oral solution.

  1. Body Weight
    Below 5 kg
    Dose
    0.5 mg/kg to 1 mg/kg (starting); up to 2.5 mg/kg (maintenance)
    Frequency
    Twice daily
    Tracking Notes
    Only for infants at least 1 month of age. Dose should be calculated carefully and administered using the oral solution.
  2. Body Weight
    5-7 kg
    Dose
    2.5 mg to 7 mg (starting); up to 12.5 mg to 17.5 mg (maintenance)
    Frequency
    Twice daily
    Tracking Notes
    Based on 0.5 mg/kg to 1 mg/kg starting dose and up to 2.5 mg/kg maintenance dose.
  3. Body Weight
    8-10 kg
    Dose
    4 mg to 10 mg (starting); up to 20 mg to 25 mg (maintenance)
    Frequency
    Twice daily
    Tracking Notes
    Based on weight-based guidelines for pediatric patients. Use the provided calibrated oral dosing syringe.
  4. Body Weight
    11-15 kg
    Dose
    5.5 mg to 15 mg (starting); up to 27.5 mg to 37.5 mg (maintenance)
    Frequency
    Twice daily
    Tracking Notes
    Dose titration should be performed under close medical supervision.
  5. Body Weight
    16-20 kg
    Dose
    8 mg to 20 mg (starting); up to 40 mg to 50 mg (maintenance)
    Frequency
    Twice daily
    Tracking Notes
    For patients reaching 20 kg or more, the maximum maintenance dose guideline shifts to 2 mg/kg twice daily (maximum 100 mg twice daily).

Formulation

TabletOral SolutionIntravenous Injection

Purpose

Treatment of partial-onset seizures in patients aged 1 month and older, as either monotherapy or adjunctive therapy.

Generic Name

Brivaracetam

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.